| |
| |
|
| Insider
Information: |
Galen Partners III L P |
| Relationship: |
Former 10% owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,474,345 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,474,345 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Derma Sciences Inc |
DSCI |
10% Owner |
2007-01-05 |
1,474,345 |
2007-01-05 |
0 |
Premium* |
|
|
Acura Pharmaceuticals Inc |
ACUR |
Former 10% owner |
2013-04-05 |
0 |
2017-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-04-30 |
4 |
S |
$2.48 |
$46,577 |
I/I |
(18,794) |
12,643,795 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-07 |
4 |
S |
$2.23 |
$46,651 |
I/I |
(20,887) |
12,334,527 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-06-04 |
4 |
S |
$2.21 |
$50,392 |
I/I |
(22,802) |
11,822,674 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-15 |
4 |
S |
$2.27 |
$53,606 |
I/I |
(23,585) |
12,090,497 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-04-10 |
4 |
S |
$2.16 |
$54,375 |
I/I |
(25,118) |
13,093,326 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-06-14 |
4 |
S |
$2.15 |
$59,800 |
I/I |
(27,814) |
11,753,244 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2015-01-08 |
4 |
S |
$0.60 |
$60,180 |
I/I |
(100,000) |
11,028,621 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2015-01-08 |
4/A |
S |
$0.60 |
$60,180 |
I/I |
(100,000) |
11,154,497 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-03 |
4 |
S |
$2.26 |
$61,249 |
I/I |
(27,117) |
12,460,714 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-04-26 |
4 |
S |
$2.55 |
$66,422 |
I/I |
(26,000) |
12,676,231 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2014-02-24 |
4 |
S |
$1.97 |
$86,024 |
I/I |
(43,747) |
11,482,379 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-16 |
4 |
S |
$2.21 |
$94,093 |
I/I |
(42,599) |
12,047,898 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-21 |
4 |
S |
$2.30 |
$108,977 |
I/I |
(47,410) |
11,877,035 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2015-06-16 |
4 |
S |
$1.08 |
$109,441 |
I/I |
(100,923) |
10,982,574 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-02 |
4 |
S |
$2.47 |
$123,344 |
I/I |
(49,937) |
12,487,831 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-17 |
4 |
S |
$2.36 |
$128,291 |
I/I |
(54,460) |
11,993,438 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-13 |
4 |
S |
$2.21 |
$160,057 |
I/I |
(72,450) |
12,201,481 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-20 |
4 |
S |
$2.39 |
$165,231 |
I/I |
(68,993) |
11,924,445 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-04-08 |
4 |
S |
$2.16 |
$173,803 |
I/I |
(80,554) |
13,138,444 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-14 |
4 |
S |
$2.44 |
$213,227 |
I/I |
(87,399) |
12,114,082 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-04-05 |
4 |
S |
$2.16 |
$215,545 |
I/I |
(99,933) |
13,218,998 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-04-11 |
4 |
S |
$2.24 |
$216,005 |
I/I |
(96,336) |
12,996,990 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Former 10% owner |
– – – |
2017-12-14 |
4 |
S |
$0.10 |
$219,573 |
I/I |
(2,195,734) |
0 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-06 |
4 |
S |
$2.12 |
$223,594 |
I/I |
(105,300) |
12,355,414 |
0 |
- |
|
| DSCI |
Derma Sciences Inc |
10% Owner |
– – • |
2007-01-05 |
4 |
A |
$0.78 |
$250,856 |
D/D |
321,734 |
1,474,345 |
0 |
- |
|
55 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
